Nanosized silver cubes can make it easier to read diagnostic tests
Engineers at Duke University have shown that nanosized silver cubes can make diagnostic tests that rely on fluorescence easier to read by making them more than 150 times brighter. Combined with an emerging point-of-care diagnostic…
NC Biotech Center awards $1.8M in grants, loans to startups, universities
RESEARCH TRIANGLE PARK – The North Carolina Biotechnology Center awarded 13 grants and loans totaling $1.8 million to universities and bioscience companies in the third quarter of its current fiscal year. The awards, made from January…
Duke Engineers Adapt Rapid Testing Platform to See If It Can Catch COVID-19
Biomedical engineers adapt simple, low-cost platform to diagnose the new coronavirus. Cassio Fontes demonstrates a prototype of the D4 assay, which might be used to quickly test for COVID antigens, using blood drops and a…
Med device startup InnAVasc founded by Duke surgeons raising $1M
InnAVasc Medical, which is developing medical devices that provide safer vascular access for patients with kidney failure, has raised $414,500 in debt, according to a securities filing. Twenty investors contributed to the round, which is capped at…
Celldom Aims to Improve Cancer Drug Screening
APRIL 21, 2020 Celldom’s microfluidics imaging technology pinpoints drug-resistant cells By Elizabeth Witherspoon [Originally published on Duke Biomedical Engineering] An acute myeloid leukemia cell line that was trapped in single-cell per chamber format at…
Phitonex Pushes the Envelope of Immunology Research with 40 Color Flow Cytometry Experiment
Phitonex, Inc., developers of next generation fluorescent labels for biomarker detection, is pushing the envelope of what is possible in flow cytometry and today publicly shared the first data set showing 40 colors measured simultaneously…
Grid Therapeutics Announces FDA Approval of IND Application for GT103
Grid Therapeutics, LLC, a biotechnology company developing a first-in-class, novel human-derived targeted immunotherapy for cancer, today announced that the U.S. Food and Drug Administration approved its investigational new drug (IND) application for GT103, Grid’s lead therapeutic…
Protecting Thin, Flexible Brain Interfaces from the Human Body
Researchers have demonstrated the ability to implant an ultrathin, flexible neural interface with thousands of electrodes into the brain with a projected lifetime of more than six years. Protected from the ravaging environment of internal…
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A
Precision BioSciences, Inc. (DTIL), a life sciences company dedicated to improving life through the application of its pioneering, proprietary ARCUS® genome editing platform, today announced the initiation of patient dosing in a Phase 1/2a clinical trial…